Key result
Mayo ATTR-CM, Kumamoto, and simplified T-Amylo scores showed strong discrimination for ATTR-CM in elderly Asian HFpEF patients (AUCs 0.95, 0.92, and 0.91, respectively).
Why the study?
Several clinical scoring systems have been proposed to improve the diagnostic likelihood of ATTR-CM, but their validity in elderly Asian patients with HFpEF was unknown.
Do the Mayo ATTR-CM score, Kumamoto criteria, and simplified T-Amylo score accurately diagnose transthyretin amyloid cardiomyopathy (ATTR-CM) in elderly Asian patients with HFpEF?
Observational (n=204)
Yes
Do the Mayo ATTR-CM score, Kumamoto criteria, and simplified T-Amylo score accurately diagnose transthyretin amyloid cardiomyopathy (ATTR-CM) in elderly Asian patients with HFpEF?
The Mayo ATTR-CM score, Kumamoto criteria, and simplified T-Amylo score all demonstrated strong diagnostic discrimination and high negative predictive value (>98%) for identifying ATTR-CM in an elderly Taiwanese HFpEF cohort.
High NPV supports ruling out ATTR-CM in elderly Asian HFpEF; extends score validation but leaves open need for prospective confirmation.
Background Among elderly patients with heart failure with preserved ejection fraction (HFpEF), transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized etiology. Recently, several scoring systems have been proposed to improve the diagnostic likelihood of ATTR-CM, but the validity in the elderly Asian HFpEF population was still unknown. Purpose This study aims to investigate the diagnostic validity of the Mayo ATTR-CM score, the Kumamoto criteria, and the simplified T-Amylo score among patients in an independent Asian multi-center HFpEF study (Prevalence of ATTR-CM in Taiwanese Elderly patients with Heart Failure with preserved Ejection Fraction, PATCH-HFpEF). Methods We evaluated the diagnostic performance of the Mayo ATTR-CM score, the Kumamoto criteria, and the simplified T-Amylo score using data from the prospectively collected PATCH-HFpEF study, which systematically screened patients ≥ 60 years with HFpEF for ATTR-CM. Analyses were performed in the overall population and in a prespecified subgroup with left ventricular posterior wall thickness (LVPWd) ≥ 12 mm. Results The PATCH-HFpEF study comprised 204 patients (49.5% male, 50.5% female) with a mean age of 79.4 ± 8.1 years. The overall prevalence of ATTR-CM in our study was 4.4%, which increased to 10.3% in the subgroup of patients with LVPWd ≥ 12 mm. In the Mayo ATTR-CM score, the optimal diagnostic cutoff by Youden index was score 7, with sensitivity 88.9% and specificity 88.7%. The positive predictive value (PPV) and negative predictive value (NPV) were 26.7% and 98.4% respectively. In the Kumamoto criteria, the optimal diagnostic cutoff by Youden index was score 2, with sensitivity 77.8% and specificity 90.3%. The PPV and NPV were 26.9% and 98.9% respectively. As for the simplified T-Amylo score, the optimal diagnostic cutoff by Youden index was score 5, with sensitivity 62.5% and specificity 92.8%. The PPV and NPV were 26.3% and 98.4% respectively. In the overall HFpEF population, the Mayo ATTR-CM score, the Kumamoto criteria, and the simplified T-Amylo score yielded AUCs of 0.95 (SE: 0.05, 95% CI: 0.86-1.05), 0.92 (SE: 0.06, 95% CI: 0.80-1.05), and 0.91 (SE: 0.07, 95% CI: 0.78-1.05), respectively. When applied to the LVPWd ≥ 12 mm subgroup, these models maintained robust diagnostic performance with AUCs of 0.90 (SE: 0.07, 95% CI: 0.77-1.04), 0.89 (SE: 0.07, 95% CI: 0.75-1.03), and 0.88 (SE: 0.08, 95% CI: 0.72-1.04), respectively. All models demonstrated appropriate calibration. We also compared the AUC in each scoring system with one another by DeLong’s test, which revealed no statistically significant (Mayo ATTR-CM v.s. Kumamoto, p=0.691, Mayo ATTR-CM v.s. T-Amylo, p=0.6516, Kumamoto v.s. T-Amylo, p=0.9433). Conclusion The Mayo ATTR-CM score, Kumamoto criteria, and simplified T-Amylo score demonstrated strong discrimination in our overall elderly HFpEF study, with preserved performance among patients with increased wall thickness.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted an observational in Transthyretin amyloid cardiomyopathy (ATTR-CM) in heart failure with preserved ejection fraction (HFpEF) (n=204). Mayo ATTR-CM score, Kumamoto criteria, and simplified T-Amylo score vs. Each scoring system compared with one another was evaluated on Diagnostic performance (AUC) for identifying ATTR-CM (AUC 0.95 (Mayo), 0.92 (Kumamoto), 0.91 (T-Amylo), 95% CI 0.86-1.05, p=0.691). Mayo ATTR-CM, Kumamoto, and simplified T-Amylo scores showed strong discrimination for ATTR-CM in elderly Asian HFpEF patients (AUCs 0.95, 0.92, and 0.91, respectively).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: